LETTER FROM MUMBAI 311
NON-PAYMENT OF PRIVATE HOSPITAL BILLS OF DYING PATIENTS
From time to time private hospitals face a
painful situation—painful to the administration and the
relatives of patients alike. Consider the following case.
A patient is admitted for treatment of an acute, severe
illness such as myocardial infarction. In view of the
emergency, the patient is admitted at once without a deposit,
on the understanding that the relatives will make the payment
within the next 12–24 hours. Intensive care, resuscitation and
all possible therapy fails to help and the patient dies. The
relatives wish to take the body away. No payment whatsoever
has been made.
The hospital is within its rights to demand payment as
agreed upon before releasing the body but an adamant stand can
boomerang upon the administration because of the adverse
publicity likely to be generated by the family in the media.
The hospital administrator is made the heartless and
avaricious villain, out to get his pound of flesh from the
harassed and bereaved family. Boorish elements make political
capital by championing the cause of the family and even
insinuating that the death was entirely the fault of the
hospital, the treatment inadequate or substandard and
attitudes of all staff members arrogant and callous.
Demonstration of medical facts testifying to the gravity of
the illness, extent of the damage done to the heart by the
loss of its blood supply and details of treatment are
disregarded as emotion overrules reason in the presence of a
television crew.
Experts pondering the issue have made the following
suggestions:
-
Public education on the responsibilities
of patients and their families to balance education on their
rights. It is patently unfair to avail of services and then
flee without meeting the costs. Casting aspersions on the
treating physicians and the institution without proof and,
in some cases, assaulting the former and damaging the latter
are indefensible.
-
Improvement of emergency services in
public sector hospitals and access to them so that those
from the poorer sections of society are confident enough to
avail of them.
-
A written undertaking by a responsible
relative guaranteeing payment of all dues should precede
emergency admissions. The difficulty here is enforcement of
the guarantee.
-
Each private hospital should create a
fund to take care of such contingencies. Bills not paid
under such tragic circumstances should be written off
against this fund.
Would readers care to offer their
suggestions and views?
STEM CELL TRANSPLANTATION IN INDIA
Many in the Indian medical profession consider stem cells to
be the answer to their prayers and those of their patients.
Unbridled enthusiasm at the prospect of enabling patients
rendered paraplegic by spinal injuries, ridding patients with
Parkinson disease of their handicaps and reversing the ravages
produced by Alzheimer disease thrill several neuroscientists.
The hope of regenerating tissues is truly tantalizing.
Others look to stem cells to study organogenesis and
understand what can and does go wrong when malformations occur
or diseases strike the organs being created from stem cells.
Hitherto, the principal debate has been over the use of
stem cells obtained from the embryo. Experts in biomedical
ethics, scholars on religion and philosophy, and regulatory
agencies have worried about the damage to the embryo,
destruction of a potential living being and the production of
embryos merely to obtain stem cells to benefit others.
The recent production of stem cells from somatic cells
obtained from the patient to be helped adds a new dimension.
This technique requires no embryo. Since the patient’s cells
are used, chances of rejection of the transplanted stem cells
are very low. The risk of inducing tumours may be eliminated
by avoiding the c-myc gene. These features may lend
further impetus to the use of cells from the skin and
elsewhere.
Experts on stem cells have expressed concern on the
inability to tag stem cells so that their course after
transplantation can be studied. Others have favoured directing
stem cells into the progenitors of the diseased cells (neurones
for example) before they are used.
Such discussions and debates are welcome and form part of
the development of any new technique or procedure. The
promises held out by stem cells must be validated
experimentally, the safety and efficacy of transplantation of
these cells confirmed in animals and by staged studies in
humans as in any other clinical trial.
To the dismay of many in India, individuals, departments
and institutions have jumped the gun in many of our states.
Stem cells are being touted as a panacea, desperate patients
and their families forming the gullible targets. Huge sums are
demanded—and paid—to doctors and clinics for such transplants.
Enquiries about earlier work done by these doctors and clinics
on stem cells elicit no response or anger at the temerity
displayed by asking such questions. A search of the published
literature yields no evidence of experiments, techniques used,
animal trials and phased clinical trials. The medical
profession has no access to follow up studies on the successes
or failures of the procedures.
A prestigious teaching institute announced the successful
use of stem cells in curing damaged hearts through the
national newspapers. Efforts at tracing the background
documents have failed thus far. It appears that the
institutional ethics committee had sanctioned this project but
there appears to be little transparency on the evidence
presented to the committee or the discussions that preceded
the sanction. A diligent search has led to just one paper on
the subject in a scientific journal. This paper—a review of
stem cells transplants—blandly reports the ‘success’ without
providing details or evidence.
At the Second National Conference on Bioethics in
Bangalore, a session on 8 December 2007 featured a discussion
on stem cells. Speaking in this session, Dr Bernard Lo,
professor of medicine and director of the programme on medical
ethics at the University of California at San Francisco,
offered comments that are relevant here. He took pains to
emphasize that our knowledge on the use of stem cells to treat
diseases and spinal cord injury is evolving and that we are
far from the stage where we can start treating patients even
on an experimental basis. He went on to add that he was aware
that such usage had already started in India but did not
possess details.
A member of the audience had an interesting question: ‘Dr
Lo, we are aware of the fact that we need to learn more about
stem cells before using them in clinical practice. Let me put
before you the plight of a young patient who has been rendered
paraplegic by an accidental spinal injury. Lacking social
services and rehabilitative measures, the fate of such a
patient is usually sealed as pressure ulcers, urinary tract
infection and eventual pneumonia take their toll. Is it
unethical to use stem cells to try and benefit such a
patient?’
Dr Lo replied: ‘I fully sympathize with the plight of the
patient you refer to. Under such circumstances, the
experimental usage of stem cells must be under strictly
controlled conditions and at a few, carefully selected centres.
The procedures to be followed must be standardized and
approved by an authoritative ethics committee. Meticulous
records must be maintained. There must be total transparency
at every stage. The patient and his family must understand
that an experiment is being conducted which may help but which
is also fraught with several uncertainties including the
possibility of complications such as the development of tumour.
The patient must be carefully observed and followed up over a
long period after the transplant. The records on the patient
should be available for scrutiny by the medical profession.
Since the treatment is of the nature of a clinical trial, the
patient should not be charged for participating in the
experiment.’
Dr P. M. Bhargava, founding director of the Centre for
Cellular and Molecular Biology, Hyderabad—a member of the
audience—gave us the benefit of his observations on the
subject. He acknowledged several instances of unauthorized and
unsupervised use of stem cells in patients in India with no
transparency. He bemoaned the lack of any statutory agency
that could act in such cases. He pleaded for a national
council of senior and experienced scientists who could foresee
developments such as those on stem cells and formulate and
table legislative measures to ensure that unscrupulous
individuals or clinics did not jettison science to enrich
themselves at the expense of desperate patients and their
families.
The Indian Council of Medical Research (ICMR) has proposed
the formation of a National Apex Committee for stem cell
therapy with ICMR itself as the Regulatory Authority. To the
best of my knowledge this has not yet been legislated.
A PLEA FOR THE INCLUSION OF AYURVEDA INTO
MODERN MEDICINE
Dr M. S. Valiathan delivered the inaugural address at the
above conference. He chose the subject Bioethics and
Ayurveda. While describing the very perceptive and
thought-provoking instructions on ethical medical instruction
and practice in the Samhitas of the schools of Charaka,
Susruta and Vaghbhata (to name but 3 of the great teachers of
the past), Dr Valiathan referred to the ‘missing domain’ in
most modern Indian medical conferences and meetings.
He pointed out that India produces over 15 000 Ayurvedic
doctors every year from over 200 colleges. He quoted estimates
of 60% of our poor villagers depending more or less on
Ayurvedic practitioners for their basic healthcare needs. ‘To
survive and flourish even after 2000 years of varied fortunes,
the traditional system must surely have intellectual and
ethical vitality and its claim to consideration in a national
discussion on bioethics would seem self-evident.’ This claim
can be extended to all branches of healthcare.
To exclude such a large number of physicians catering to a
vast segment of our population from our deliberations and the
planning and execution of healthcare programmes can only be to
the detriment of our people.
He pleaded for an effort—however difficult and
time-consuming it may be—to integrate Ayurvedic experts and
practitioners into modern medicine.
WE ARE PLUMBING EVER FURTHER DEPTHS IN
MEDICAL MALPRACTICE
The Times of India (17 December 2007) informed its readers
in Mumbai of ‘a case of autopsies being conducted on the basis
of instructions given over phone by the doctor on duty’.
Representatives of the Police Surgeon have been placed at
some of our large public hospitals. They are required to
perform autopsies for medicolegal purposes. Since the
scrapping of the Coroner’s Act, they represent the law in
these hospitals and their findings are crucial in all legal
hearings on these deaths.
At the Bhagwati Hospital, run by the Municipal Corporation
in Borivali—a suburb in north-west Mumbai—Dr Abhijeet Gawde
was the pathologist on duty to perform autopsies on 21
November 2007. He did not report for work. Worse, ‘when the
bodies started coming in for autopsy, he issued instructions
over the phone’ to the unqualified staff in the autopsy room.
Still worse, ‘the doctor would give (the unqualified staff)
necessary instructions to list the cause of death and issue
certificates’ without his ever having seen the body or
witnessed the autopsy findings.
It is a telling commentary on the state of affairs in the
Police Surgeon’s department that this practice came to light
only when a sub-inspector came to the centre to get the
autopsy of a relative done. ‘The officer noticed that even
though there was no doctor present at the place, the
postmortem was being done. The death certificate, too, was
issued to him. When he asked the employees what was going on,
they gave evasive answers, prompting him to lodge a complaint
with police surgeon, Dr S. M. Patil, who is in charge of all
postmortem centres in the city. The police surgeon confirmed
having received a complaint from the sub-inspector.’ Dr Patil
is reported to have said: ‘It is shocking to learn that the
employees were allowed to issue a death certificate in the
absence of the doctor and even fill in the details, which they
are not supposed to do.’ Apparently it was not shocking that
Dr Gawde did not perform the autopsy and was not even present
when it was carried out.
The news report mentions in passing that Dr Gawde was
trapped by the anticorruption bureau the following day for
demanding and accepting money from another doctor for writing
a favourable report.
Several questions arise. The following worry me most. Are
pathologists appointed to these posts carefully scrutinized
and periodically re-evaluated regarding their qualifications,
aptitude, fitness to work and quality of performance? Are the
activities of these pathologists not subject to periodic
scrutiny by the Police Surgeon? Is there no system whereby
findings at each autopsy are recorded, perhaps on video
camera, since they will form the basis of judgments in court?
Dr Gawde has probably been misbehaving and showing evidence of
blatant malpractice and corruption over time. Are his
autopsies, reports and certificates going to be re-evaluated
by experts so that the full truth can see the light of day?
If currents trends prevail—as well they might—this
unwelcome publicity of Dr Gawde’s activities will blow over as
newspapers turn to other news stories and Dr Gawde may return
to practice
as usual.
|